Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IL1A Antikörper

Der Ziege Polyklonal Anti-IL1A-Antikörper wurde für WB, EIA, IHC (p) und Func validiert. Er ist geeignet, IL1A in Proben von Ratte zu detektieren.
Produktnummer ABIN116387

Kurzübersicht für IL1A Antikörper (ABIN116387)

Target

Alle IL1A Antikörper anzeigen
IL1A (Interleukin 1 alpha (IL1A))

Reaktivität

  • 121
  • 56
  • 39
  • 13
  • 12
  • 11
  • 10
  • 9
  • 9
  • 6
  • 5
  • 4
  • 4
Ratte

Wirt

  • 152
  • 54
  • 7
  • 7
  • 6
  • 2
  • 2
  • 1
  • 1
Ziege

Klonalität

  • 167
  • 63
  • 1
Polyklonal

Konjugat

  • 122
  • 47
  • 18
  • 10
  • 8
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IL1A Antikörper ist unkonjugiert

Applikation

  • 161
  • 87
  • 87
  • 50
  • 44
  • 36
  • 19
  • 12
  • 11
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Functional Studies (Func)
  • Spezifität

    This antibody reacts with Rat Interleukin 1 alpha

    Aufreinigung

    Affinity chromatography

    Immunogen

    Recombinant rat IL-1 alpha
  • Applikationshinweise

    Immunohistochemistry: we recommend use of 1 μg per ml as a starting dilution. Paraffin sections may require pretreatment like Proteinase K or Trypsin predigestion toimprove staining. Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity of rIL-1alpha (50 pg/mL), a concentration of 0.011-0.017 μg/mL of this antibody is required. ELISA: To detect rIL-1 alpha by direct ELISA (using 100 ml/well antibody solution) aconcentration of at least 0.5 μg/mL of this antibody is required. This antigen affinitypurified antibody, in conjunction with compatible secondary reagents, allows the detectionof 0.2-0.4 ng/well of recombinant rIL-1 alpha. Western blot: To detect rIL-1 alpha by Western Blot analysis this antibody can be used at aconcentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagentsthe detection limit for recombinant rIL-1 alpha is 1.5-3.0 ng/lane, under either reducing ornon-reducing conditions.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Rekonstitution

    Restore in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, pH 7.2 without preservatives.

    Konservierungsmittel

    Without preservative

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.
  • Target

    IL1A (Interleukin 1 alpha (IL1A))

    Andere Bezeichnung

    Interleukin-1 alpha / IL-1A

    Hintergrund

    Interleukins (ILs) are a large group of cytokines that are produced mainly by leukocytes, although some are produced by certain phagocytes and auxiliary cells. Each IL acts on a specific, limited group of cells through a receptor specific for that IL. Interleukin 1 (IL1), originally known as lymphocyte activating factor (LAF), activates T cells and lymphocytes, which then proliferate and secrete interleukin 2. IL1 is primarily released from stimulated macrophages and monocytes, but also is released from several other cell types and is thought to play a key role in inflammatory and immune responses. The two closely related agents, interleukin 1 alpha (IL1 alpha) and interleukin 1 beta (IL1 beta) bind to the same cell surface receptor, elicit nearly identical biological responses and share 25 % homology in their amino acid sequence.Synonyms: Hematopoietin-1, IL-1 alpha, IL1A, IL1F1

    Gen-ID

    24493

    NCBI Accession

    NP_058715

    UniProt

    P16598

    Pathways

    NF-kappaB Signalweg, Autophagie, Cancer Immune Checkpoints
Sie sind hier:
Chat with us!